Prognostic significance of neutrophil-to-lymphocyte ratio in cervical cancer: A systematic review and meta-analysis of observational studies

Qi-Tao Huang; Qian-Qian Man; Jia Hu; Yi-lin Yang; Yue-Mei Zhang; Wei Wang; Mei Zhong; Yan-Hong Yu

doi:10.18632/oncotarget.15157

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Prognostic significance of neutrophil-to-lymphocyte ratio in cervical cancer: A systematic review and meta-analysis of observational studies

Qi-Tao Huang _, Qian-Qian Man, Jia Hu, Yi-lin Yang, Yue-Mei Zhang, Wei Wang, Mei Zhong and Yan-Hong Yu

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:16755-16764. https://doi.org/10.18632/oncotarget.15157

Metrics: PDF 2044 views | HTML 4687 views | ?

Abstract

Qi-Tao Huang1, Qian-Qian Man2, Jia Hu2, Yi-Lin Yang2, Yue-Mei Zhang2, Wei Wang1, Mei Zhong1, Yan-Hong Yu1

1Division of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China

2Southern Medical University, Guangzhou, 510515, China

Correspondence to:

Qi-Tao Huang, email: [email protected]

Mei Zhong, email: [email protected]

Keywords: cervical cancer, inflammatory, neutrophil, lymphocyte, prognosis

Received: September 01, 2016 Accepted: January 06, 2017 Published: February 06, 2017

ABSTRACT

Background and aims: The prognostic role of neutrophil-to-lymphocyte ratio (NLR) in cervical cancer are controversial. We conducted this meta-analysis to obtain a more accurate assessment of prognostic significance of NLR in cervical cancer.

Results: A total of 9 studies, consisting of 2,804 patients, were selected in this meta-analysis. Our pooled results showed that high pre-treatment NLR level was significantly associated with poorer overall survival (HR: 1.88, 95% CI 1.30–2.73) and shorter progression free survival (HR 1.65, 95% CI 1.18–2.29). Additionally, increased NLR was also significantly correlated with tumor size (OR 2.05, 95% CI 1.14–3.65), advanced FIGO stage (OR 2.12, 95% CI1.28–3.49) and lymph node involvement (OR 2.24, 95% CI 1.65–3.04).

Materials and Methods: We conducted a systematic literature search using the electronic databases PubMed, Web of Science, and Embase up to May 2016.Statistical analysis was performed using Stata 10.0.

Conclusions: Elevated pretreatment NLR could serve as a predicative factor of poor prognosis for cervical cancer patients.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15157

Publication Alerts

Research Papers:

Prognostic significance of neutrophil-to-lymphocyte ratio in cervical cancer: A systematic review and meta-analysis of observational studies

Abstract